Skip to main content
. 2017 Oct 31;13(6):1383–1393. doi: 10.5114/aoms.2017.71066

Figure 2.

Figure 2

A – Overall survival of patients in the surgery + sorafenib group and surgery only group. B – Overall survival of patients with BCLC stage B disease in the surgery + sorafenib group and surgery only group. C – Overall survival of patients with BCLC stage C disease in the surgery + sorafenib group and surgery group